100 related articles for article (PubMed ID: 8225404)
21. Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha.
Lum HD; Buhtoiarov IN; Schmidt BE; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
Immunology; 2006 Jun; 118(2):261-70. PubMed ID: 16771862
[TBL] [Abstract][Full Text] [Related]
22. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity.
Ignatowski TA; Spengler RN
J Neuroimmunol; 1995 Aug; 61(1):61-70. PubMed ID: 7560013
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the membrane form of tumour necrosis factor-alpha in lipopolysaccharide-induced priming of mouse peritoneal macrophages for enhanced nitric oxide response to lipopolysaccharide.
Ancuta P; Fahmi H; Pons JF; Le Blay K; Chaby R
Immunology; 1997 Oct; 92(2):259-66. PubMed ID: 9415035
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.
McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH
Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840
[TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
Rashid G; Korzets Z; Bernheim J
Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E2 down-regulates viable Bacille Calmette-Guérin-induced macrophage cytotoxicity against murine bladder cancer cell MBT-2 in vitro.
Yamada H; Kuroda E; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
Clin Exp Immunol; 2002 Apr; 128(1):52-8. PubMed ID: 11982590
[TBL] [Abstract][Full Text] [Related]
27. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
[TBL] [Abstract][Full Text] [Related]
28. In vitro differentiation and characterization of human peritoneal macrophages from CAPD-peritonitis patients.
Burger M; Almanasreh N; Bauermeister K; Knopf HP; Schollmeyer P; Dobos GJ
Immunobiology; 1999 Feb; 200(1):62-76. PubMed ID: 10084696
[TBL] [Abstract][Full Text] [Related]
29. Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release.
Formica S; Roach TI; Blackwell JM
Immunology; 1994 May; 82(1):42-50. PubMed ID: 8045593
[TBL] [Abstract][Full Text] [Related]
30. Regulation by dietary essential fatty acid balance of tumor necrosis factor production in mouse macrophages.
Watanabe S; Onozaki K; Yamamoto S; Okuyama H
J Leukoc Biol; 1993 Feb; 53(2):151-6. PubMed ID: 7680370
[TBL] [Abstract][Full Text] [Related]
31. Production of cytokines and PGE2 and cytotoxicity of stimulated bone marrow macrophages after thermal injury and cytotoxicity of stimulated U-937 macrophages.
Ogle CK; Guo X; Wu JZ; Ogle JD
Inflammation; 1993 Oct; 17(5):583-94. PubMed ID: 8225565
[TBL] [Abstract][Full Text] [Related]
32. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
Rashid G; Gittel H; Ben-Efraim S
Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
[TBL] [Abstract][Full Text] [Related]
33. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
[TBL] [Abstract][Full Text] [Related]
34. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
35. Haemorrhagic shock in mice--intracellular signalling and immunomodulation of peritoneal macrophages' LPS response.
Rani M; Husain B; Lendemans S; Schade FU; Flohé S
Immunobiology; 2006; 211(9):711-9. PubMed ID: 17015146
[TBL] [Abstract][Full Text] [Related]
36. Differential stimulation of macrophages for tumor cytostasis and monokine production.
Sarih M; Souvannavong V; Adam A
Cancer Lett; 1992 Jul; 64(3):187-94. PubMed ID: 1638511
[TBL] [Abstract][Full Text] [Related]
37. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
38. TNF-alpha differentially regulates Ia antigen expression and macrophage tumoricidal activity in two murine macrophage cell lines.
Wynn TA; Freund YR; Paulnock DM
Cell Immunol; 1992 Mar; 140(1):184-96. PubMed ID: 1310901
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the correlation between nitrite concentration and listericidal activity in cultures of resident and elicited murine macrophages.
Higginbotham JN; Pruett SB
Clin Exp Immunol; 1994 Jul; 97(1):100-6. PubMed ID: 8033406
[TBL] [Abstract][Full Text] [Related]
40. Peritonitis-induced antitumor activity of peritoneal macrophages from uremic patients.
Turyna B; Jurek A; Gotfryd K; Siaśkiewicz A; Kubit P; Klein A
Folia Histochem Cytobiol; 2004; 42(3):147-53. PubMed ID: 15493575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
